
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18298572
[patent_doc_number] => 20230108258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE)
[patent_app_type] => utility
[patent_app_number] => 17/881754
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881754 | ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE) | Aug 4, 2022 | Pending |
Array
(
[id] => 18308927
[patent_doc_number] => 20230112827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/864757
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864757 | BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES | Jul 13, 2022 | Abandoned |
Array
(
[id] => 17981074
[patent_doc_number] => 20220347110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/859481
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17859481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/859481 | MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE | Jul 6, 2022 | Abandoned |
Array
(
[id] => 18221310
[patent_doc_number] => 20230060304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/855553
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855553 | Neutralizing antibodies to GP120 and their use | Jun 29, 2022 | Issued |
Array
(
[id] => 18020578
[patent_doc_number] => 20220372077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
[patent_app_type] => utility
[patent_app_number] => 17/844509
[patent_app_country] => US
[patent_app_date] => 2022-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844509 | ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING | Jun 19, 2022 | Abandoned |
Array
(
[id] => 17944367
[patent_doc_number] => 20220331384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS OF TREATING BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/842406
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842406 | Methods of treating bladder cancer | Jun 15, 2022 | Issued |
Array
(
[id] => 20414382
[patent_doc_number] => 12497655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Compositions, methods and kits to detect adenovirus, metapneumovirus and/or rhinovirus nucleic acids
[patent_app_type] => utility
[patent_app_number] => 17/834578
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19109
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834578 | Compositions, methods and kits to detect adenovirus, metapneumovirus and/or rhinovirus nucleic acids | Jun 6, 2022 | Issued |
Array
(
[id] => 19593167
[patent_doc_number] => 12150985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Immunogenic and vaccine compositions against SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 17/804954
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 52
[patent_no_of_words] => 27638
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17804954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/804954 | Immunogenic and vaccine compositions against SARS-CoV-2 | May 31, 2022 | Issued |
Array
(
[id] => 18183157
[patent_doc_number] => 20230043887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPOSITIONS AND METHODS RELATED TO SURGE-ASSOCIATED SARS-COV-2 MUTANTS
[patent_app_type] => utility
[patent_app_number] => 17/750817
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750817 | COMPOSITIONS AND METHODS RELATED TO SURGE-ASSOCIATED SARS-COV-2 MUTANTS | May 22, 2022 | Pending |
Array
(
[id] => 18003611
[patent_doc_number] => 20220362377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC
[patent_app_type] => utility
[patent_app_number] => 17/750029
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750029 | MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC | May 19, 2022 | Abandoned |
Array
(
[id] => 18434424
[patent_doc_number] => 20230181718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METHODS AND COMPOSITIONS RELATED TO VIRAL VACCINES WITH IMPROVED PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/743762
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743762 | METHODS AND COMPOSITIONS RELATED TO VIRAL VACCINES WITH IMPROVED PROPERTIES | May 12, 2022 | Abandoned |
Array
(
[id] => 18005349
[patent_doc_number] => 20220364115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => ENHANCED PROMOTER
[patent_app_type] => utility
[patent_app_number] => 17/731027
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731027 | ENHANCED PROMOTER | Apr 26, 2022 | Abandoned |
Array
(
[id] => 17881181
[patent_doc_number] => 20220296658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHODS OF TREATING BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/713975
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713975 | Methods of treating bladder cancer | Apr 4, 2022 | Issued |
Array
(
[id] => 18565753
[patent_doc_number] => 20230256080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS
[patent_app_type] => utility
[patent_app_number] => 17/712600
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712600 | VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS | Apr 3, 2022 | Pending |
Array
(
[id] => 17930237
[patent_doc_number] => 20220325362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/709571
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709571 | VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS | Mar 30, 2022 | Pending |
Array
(
[id] => 19563554
[patent_doc_number] => 12138305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Nucleoside-modified RNA for inducing an adaptive immune response
[patent_app_type] => utility
[patent_app_number] => 17/705837
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 39369
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705837 | Nucleoside-modified RNA for inducing an adaptive immune response | Mar 27, 2022 | Issued |
Array
(
[id] => 17946161
[patent_doc_number] => 20220333178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS FOR IMPROVING NUCLEIC ACID CLUSTER CLONALITY
[patent_app_type] => utility
[patent_app_number] => 17/699573
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699573 | METHODS FOR IMPROVING NUCLEIC ACID CLUSTER CLONALITY | Mar 20, 2022 | Abandoned |
Array
(
[id] => 17898385
[patent_doc_number] => 20220308047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => PROBES COMPRISING METAL NANOPARTICLES, MAGNETIC NANOPARTICLES AND TARGET-SPECIFIC FLUOROPHORES OR BINDING SITES
[patent_app_type] => utility
[patent_app_number] => 17/697638
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697638 | PROBES COMPRISING METAL NANOPARTICLES, MAGNETIC NANOPARTICLES AND TARGET-SPECIFIC FLUOROPHORES OR BINDING SITES | Mar 16, 2022 | Pending |
Array
(
[id] => 17750024
[patent_doc_number] => 20220228229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Methods of Detecting Influenza
[patent_app_type] => utility
[patent_app_number] => 17/693776
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693776 | Methods of Detecting Influenza | Mar 13, 2022 | Pending |
Array
(
[id] => 17720455
[patent_doc_number] => 20220213175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => CORONAVIRUS: EARLY DETECTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/653207
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653207 | CORONAVIRUS: EARLY DETECTION AND TREATMENT | Mar 1, 2022 | Abandoned |